neubourg group

Name

neubourg group

Legal name

AVIA Pharma Germany

Website

https://neubourg.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Dermo-cosmetic and pharmaceutical skin care products

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Hand & Foot Care (CRABAAAE), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

Keywords

• Medical skin care
• Foot care products
• Allergology treatments
• Nail correction systems
• Dermo-cosmetic products

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical/Medical Product Sales: Revenue generated through sale of branded medical skin health products, foot care products, nail correction solutions, and allergology products across multiple brands.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

neubourg group, via its subsidiary AVIA Pharma Germany, develops, manufactures, and distributes a multi-brand portfolio of medical skin health, allergology, foot care, and nail correction products. The portfolio encompasses six brands (Allergika, Allpresan, Podoexpert, Onyfix, Fußpunkt, Sixtus) addressing four therapeutic application areas: encasings for allergy prevention, medical skincare, foot care, and nail correction. Products are sold through pharmacy wholesale and direct-to-consumer e-commerce channels in Germany.

Product overview

AVIA Pharma Germany, part of neubourg group, is a specialist for medical skin health and allergology. The company operates a multi-brand portfolio strategy, offering products through six main brands: Allpresan (foot care), Podoexpert (professional foot care by Allpresan), Onyfix (nail correction), Fußpunkt (foot care), Sixtus (wellness/foot care), and Allergika (allergy products). Products are organized into four application areas: Encasings (allergen-protective bedding covers), Medical Skincare (medizinische Hautpflege), Foot Care (Fußpflege), and Nail Correction (Nagelkorrektur). The company develops, manufactures, and distributes medical devices and cosmetics for dermatological and allergological applications.

Differentiator

Problem solved

Functional benefit

Brands

• Allergika: Dermatological skincare and allergy products
• Allpresan
• Podoexpert
• Onyfix
• Fußpunkt
• Sixtus

Products and services

• Allpresan

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• CeraVe: L'Oréal-owned dermocosmetics brand developed with dermatologists, focused on barrier repair and sensitive skin. Closely overlaps Allergika's sensitive-skin and barrier-repair positioning, with vastly larger marketing investment.
• STADA Arzneimittel: German-headquartered generics and consumer healthcare company with dermatology, foot care, and allergy brands sold through European pharmacies. Comparable to AVIA in pharmacy-channel consumer health, particularly in foot care and allergology.
• Almirall: European specialty pharmaceutical company focused on dermatology (e.g., Actinicel, Ciclopoli, Solaraze). Comparable in dermatology prescription and dermo-cosmetic adjacencies, with a similar European pharmacy-and-dermatologist GTM motion.
• Galderma: Global pure-play dermatology company covering prescription, aesthetics, and consumer skincare (Cetaphil, Differin, etc.). Overlaps with AVIA in dermatology and sensitive-skin categories, though at substantially greater scale and geographic reach.
• Beiersdorf: German incumbent behind Eucerin (dermocosmetics) and Nivea. Eucerin directly overlaps AVIA's medical-grade skincare portfolio, while Beiersdorf's scale and R&D budget represent the dominant competitive benchmark in German pharmacy channels.
• La Roche-Posay: L'Oréal-owned dermocosmetics brand distributed globally through pharmacies and recommended by dermatologists. Directly overlaps AVIA's Allergika/Solar/medical skincare positioning at much larger scale.
• Dermapharm Holding: German specialty pharmaceutical company with a strong dermatology portfolio (e.g., Linola, Dermapharm brands) sold through pharmacies and physicians. Comparable in therapeutic focus (dermatology, allergology) and German pharmacy channel.
• Pierre Fabre Dermo-Cosmétique: French dermo-cosmetic and dermatology company (Avène, Ducray, Klorane, A-Derma). Comparable in medical-grade skincare positioning and pharmacy distribution model, particularly relevant for AVIA's sensitive-skin and allergology brands.

Direct peers

• Dr. Wolff Group: Mid-sized German consumer healthcare company with brands including Alpecin, Plantur, Linola, and Biorepair. Directly comparable to AVIA in size, German pharmacy distribution model, and medical/dermatological consumer health positioning.
• Sebapharma: German manufacturer of sebamed, a clinically positioned dermo-cosmetic and medical skincare brand sold through pharmacies and healthcare professionals. Closest comparable in country, channel, and medical-grade positioning to AVIA's Allergika and Sixtus brands.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/neubourg-skin-care-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about neubourg group